AbbVie

Associate Director, Program Management, Pipeline Commercialization

Posted on: 28 Jan 2021

Irvine, CA

Job Description

About AbbVie
AbbVies mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on peoples lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, womens health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

The Associate Director, Program Management, Pipeline Commercialization provides program management support for assigned Allergan assets. The Associate Director will facilitate the advancement of assigned assets from early development to commercial launch using AbbVies Pipeline Commercialization Model. This includes partnering with Chemistry, Manufacturing, and Controls (CMC) teams, Product Presentation and Device Strategy (PPDST) teams, and acting as a cross-functional leader and strategic influencer to each.

Significant drug development experience within a scientific, operations, commercial, or project management capacity will be crucial to success in this role. Experience in the CMC space is a strong plus.

Key Responsibilities:

* Supports the implementation of the Pipeline Commercialization Model (PCM) for Allergan Programs.
* Provides Program Management (PM) support for assigned Product Presentation and Device Strategy Teams (PPDSTs) within the Pipeline Commercialization Model.
* Supports development of PPDST plans and drives aligned execution.
* Ensures accurate and timely tracking and reporting of PPDST deliverables. Identifies, communicates, and manages risks to PPDST deliverables.
* Actively participates in the advancement of Program Management and asset development capabilities for AbbVie overall.

Detailed Responsibilities

1. Supports implementation of the Pipeline Commercialization Model for Allergan Programs
* Provides Program Management (PM) support for assigned AGN CMC (Chemistry, Manufacturing, and Controls) teams and supports the transition of these teams to Product Presentation and Device Strategy Teams (PPDSTs). The PPDST is the CMC deliverable team within the Pipeline Commercialization Model (PCM)
2. Provides Program Management (PM) support for assigned PPDSTs.
* Serve as a core member of the assigned PPDSTs supporting multiple assets.
* Serve as a key business partner for the PPDST co-chairs in developing core strategies and meeting the PPDSTs goals.
* Operate with a strategic, cross-functional mindset.
* Coordinate PPDST activities and deliverables and supports the co-chairs in driving cross-functional alignment within PPDST. Structures PPDST meetings and discussions to drive good decision-making practices.
* Ensure effective management of PPDST meetings including scheduling, agendas, minutes, action item follow-up.
* Partner with Asset Team Project Manager and help PPDST prepare key messages and deliverables to be brought forward to the Asset Strategy team.
* Contribute to PPDST discussions both from a PM functional perspective, and a cross-functional strategic perspective.
* Ensure that the PPDST is performing well, through monitoring and assessing the teams performance and effective partnership with the PPDST co-chairs and the Asset Team PM.
3. Supports development of PPDST plans and drives aligned execution
* In partnership with the PPDST co-chairs, drives and contributes to the development of PPDST plans and deliverables to inform asset strategy. Works with the team to translate the asset strategy into execution for the PPDST and supporting CMC sub-teams.
* Keeps up to date on upcoming deliverables as a part of the asset development lifecycle to ensure the PPDST is prepared.
* Proactively identifies challenges for execution, both within the PPDST and across deliverable teams. Partners with asset PM to manage the challenge or escalate, as appropriate.
* Ensures accurate and timely tracking and reporting of PPDST deliverables. Identifies, communicates, and manages risks to PPDST deliverables.
* Partners with project planners to ensure appropriate and accurate tracking and reporting of PPDST deliverable timelines.
* Stays up to date on PPDST deliverables and upcoming asks from the asset team.
* Ensures appropriate team document management practices and maintains team Sharepoint site.
* Partners with team members to proactively identify, communicate and manage PPDST risks, escalating as appropriate for asset-level risks.
4. Actively participates in the advancement of Program Management and asset development at AbbVie
* Proactively seeks learnings from other teams and shares best practices.
* Partners with colleagues in the PM organization and the PPDST to seek process-improvement opportunities and to participate in developing and implementing change when needed.
* Actively champions the AbbVie drug development process for the assigned PDDST and seeks opportunities to increase PPDST effectiveness within the AbbVie model.

Qualifications
* Bachelors degree is required.
* 7+ years of experience in the pharmaceutical industry in a variety of roles in at least one role/functional area associated with drug development (research and development, commercial, project management, operations),
* Experience within the Chemistry, Manufacturing, and Control (CMC) space is strongly preferred.
* 4+ years in a cross-functional project / program management role.
* Strong program management skills and knowledge of program management practices and common tools used in the pharmaceutical industry.
* Excellent communication skills both written and oral.
* Excellent strategic thinking and leadership skills.

Significant Work Activities
Continuous sitting for prolonged periods (more than 2 consecutive hours in an 8 hour day)
Travel
No
Job Type
Experienced
Schedule
Full-time
Job Level Code
IC
Equal Employment Opportunity
At AbbVie, we value bringing together individuals from diverse backgrounds to develop new and innovative solutions for patients. As an equal opportunity employer we do not discriminate on the basis of race, color, religion, national origin, age, sex (including pregnancy), physical or mental disability, medical condition, genetic information gender identity or expression, sexual orientation, marital status, protected veteran status, or any other legally protected characteristic.

AbbVie

Chicago, IL

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström’s macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection.

It also provides KALETRA, an anti-human immunodeficiency virus (HIV)-1 medicine used with other anti-HIV-1 medications to maintain viral suppression in HIV-1 patients; NORVIR, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and SYNAGIS to prevent respiratory syncytial virus infection at-risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron to treat prostate cancer, endometriosis, and central precocious puberty, as well as anemia.

Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson’s disease; Sevoflurane, an anesthesia product; and ORILISSA, a non-peptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain. It has collaborations with Alector, Inc.; Janssen Biotech, Inc.; Galapagos; Bristol-Myers Squibb Company; and Calico Life Sciences LLC. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Similar Jobs